379 related articles for article (PubMed ID: 31432449)
41. RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.
Ramachandran PS; Bhattarai S; Singh P; Boudreau RL; Thompson S; Laspada AR; Drack AV; Davidson BL
PLoS One; 2014; 9(4):e95362. PubMed ID: 24759684
[TBL] [Abstract][Full Text] [Related]
42. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types.
Yvert G; Lindenberg KS; Devys D; Helmlinger D; Landwehrmeyer GB; Mandel JL
Hum Mol Genet; 2001 Aug; 10(16):1679-92. PubMed ID: 11487572
[TBL] [Abstract][Full Text] [Related]
43. A Complete Association of an intronic SNP rs6798742 with Origin of Spinocerebellar Ataxia Type 7-CAG Expansion Loci in the Indian and Mexican Population.
Faruq M; Magaña JJ; Suroliya V; Narang A; Murillo-Melo NM; Hernández-Hernández O; Srivastava AK; Mukerji M
Ann Hum Genet; 2017 Sep; 81(5):197-204. PubMed ID: 28597910
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model.
Yu X; Muñoz-Alarcón A; Ajayi A; Webling KE; Steinhof A; Langel Ü; Ström AL
J Mol Neurosci; 2013 Jul; 50(3):586-99. PubMed ID: 23592174
[TBL] [Abstract][Full Text] [Related]
45. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
46. Loss of zebrafish Ataxin-7, a SAGA subunit responsible for SCA7 retinopathy, causes ocular coloboma and malformation of photoreceptors.
Carrillo-Rosas S; Weber C; Fievet L; Messaddeq N; Karam A; Trottier Y
Hum Mol Genet; 2019 Mar; 28(6):912-927. PubMed ID: 30445451
[TBL] [Abstract][Full Text] [Related]
47. Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.
Ramachandran PS; Boudreau RL; Schaefer KA; La Spada AR; Davidson BL
Mol Ther; 2014 Sep; 22(9):1635-42. PubMed ID: 24930601
[TBL] [Abstract][Full Text] [Related]
48. Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.
Ward JM; Stoyas CA; Switonski PM; Ichou F; Fan W; Collins B; Wall CE; Adanyeguh I; Niu C; Sopher BL; Kinoshita C; Morrison RS; Durr A; Muotri AR; Evans RM; Mochel F; La Spada AR
Cell Rep; 2019 Jan; 26(5):1189-1202.e6. PubMed ID: 30699348
[TBL] [Abstract][Full Text] [Related]
49. The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
Alves S; Cormier-Dequaire F; Marinello M; Marais T; Muriel MP; Beaumatin F; Charbonnier-Beaupel F; Tahiri K; Seilhean D; El Hachimi K; Ruberg M; Stevanin G; Barkats M; den Dunnen W; Priault M; Brice A; Durr A; Corvol JC; Sittler A
Acta Neuropathol; 2014 Nov; 128(5):705-22. PubMed ID: 24859968
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7.
Noma S; Ohya-Shimada W; Kanai M; Ueda K; Nakamura T; Funakoshi H
Neurosci Res; 2012 Jun; 73(2):115-21. PubMed ID: 22426494
[TBL] [Abstract][Full Text] [Related]
51. Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunction.
Guyenet SJ; Mookerjee SS; Lin A; Custer SK; Chen SF; Sopher BL; La Spada AR; Ellerby LM
Hum Mol Genet; 2015 Jul; 24(14):3908-17. PubMed ID: 25859008
[TBL] [Abstract][Full Text] [Related]
52. Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients.
Einum DD; Townsend JJ; Ptácek LJ; Fu YH
Neurogenetics; 2001 Mar; 3(2):83-90. PubMed ID: 11354830
[TBL] [Abstract][Full Text] [Related]
53. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.
Martin J; Van Regemorter N; Del-Favero J; Löfgren A; Van Broeckhoven C
J Neurol Sci; 1999 Sep; 168(1):37-46. PubMed ID: 10500272
[TBL] [Abstract][Full Text] [Related]
54. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
[TBL] [Abstract][Full Text] [Related]
55. Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7.
Fusco AF; Pucci LA; Switonski PM; Biswas DD; McCall AL; Kahn AF; Dhindsa JS; Strickland LM; La Spada AR; ElMallah MK
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34160002
[TBL] [Abstract][Full Text] [Related]
56. First families with spinocerebellar ataxia type 7 in Poland.
Dulski J; Al-Shaikh RH; Prudencio M; Petrucelli L; Sulek A; Bernatowicz K; Sławek J; Wszolek ZK
Neurol Neurochir Pol; 2023; 57(3):310-313. PubMed ID: 37283503
[TBL] [Abstract][Full Text] [Related]
57. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.
Mookerjee S; Papanikolaou T; Guyenet SJ; Sampath V; Lin A; Vitelli C; DeGiacomo F; Sopher BL; Chen SF; La Spada AR; Ellerby LM
J Neurosci; 2009 Dec; 29(48):15134-44. PubMed ID: 19955365
[TBL] [Abstract][Full Text] [Related]
58. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.
Yvert G; Lindenberg KS; Picaud S; Landwehrmeyer GB; Sahel JA; Mandel JL
Hum Mol Genet; 2000 Oct; 9(17):2491-506. PubMed ID: 11030754
[TBL] [Abstract][Full Text] [Related]
59. RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7.
Suárez-Sánchez R; Ávila-Avilés RD; Hernández-Hernández JM; Sánchez-Celis D; Azotla-Vilchis CN; Gómez-Macías ER; Leyva-García N; Ortega A; Magaña JJ; Cisneros B; Hernández-Hernández O
Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675972
[TBL] [Abstract][Full Text] [Related]
60. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
Holmberg M; Duyckaerts C; Dürr A; Cancel G; Gourfinkel-An I; Damier P; Faucheux B; Trottier Y; Hirsch EC; Agid Y; Brice A
Hum Mol Genet; 1998 May; 7(5):913-8. PubMed ID: 9536097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
